CAPASSO, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 174
AS - Asia 169
NA - Nord America 138
SA - Sud America 35
AF - Africa 4
OC - Oceania 1
Totale 521
Nazione #
US - Stati Uniti d'America 129
RU - Federazione Russa 114
SG - Singapore 74
CN - Cina 55
BR - Brasile 30
VN - Vietnam 15
DE - Germania 13
HK - Hong Kong 12
IT - Italia 12
FR - Francia 9
FI - Finlandia 8
IN - India 5
SE - Svezia 5
GB - Regno Unito 4
MX - Messico 4
AR - Argentina 3
CA - Canada 3
PL - Polonia 3
BD - Bangladesh 2
JP - Giappone 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BW - Botswana 1
BZ - Belize 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
IL - Israele 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
OM - Oman 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 521
Città #
Singapore 44
Moscow 30
Ashburn 19
San Jose 18
Dallas 16
Beijing 12
Hong Kong 12
Los Angeles 10
Shanghai 10
Boardman 6
Hefei 6
Lauterbourg 6
Da Nang 4
Helsinki 4
Munich 4
Brooklyn 3
Ho Chi Minh City 3
Milan 3
New York 3
Nuremberg 3
Orem 3
Querétaro City 3
Rome 3
Warsaw 3
Atlanta 2
Chennai 2
Guangzhou 2
Hangzhou 2
Hanoi 2
Jiaxing 2
Lappeenranta 2
Seattle 2
Shenzhen 2
São Paulo 2
Tokyo 2
Turku 2
Zhengzhou 2
Alessandria 1
Aparecida de Goiânia 1
Belize City 1
Bochum 1
Boston 1
Brasília 1
Bridgetown 1
Brussels 1
Buffalo 1
Bắc Ninh 1
Bến Tre 1
Camden 1
Cape Town 1
Caseros 1
Charlotte 1
Chicago 1
City of London 1
Cleveland 1
Coronel Dorrego 1
Cotia 1
Council Bluffs 1
Curitiba 1
Denver 1
Dionísio Cerqueira 1
Dushanbe 1
Eldorado do Sul 1
Erechim 1
Falkenstein 1
Frankfurt am Main 1
Gaborone 1
Garibaldi 1
Guaratinguetá 1
Handan 1
Houston 1
Indiaporã 1
Irati 1
Jacareí 1
Joinville 1
Kassel 1
Kyiv 1
Langfang 1
Limeira 1
Manaus 1
Manises 1
Manta 1
Mesquita 1
Mexico City 1
Moreno Valley 1
Mumbai 1
Muscat 1
New Delhi 1
Nice 1
Nilópolis 1
North Charleston 1
Ottawa 1
Panorama City 1
Peruíbe 1
Poplar 1
Porciúncula 1
Praia Grande 1
Pune 1
Raleigh 1
San Francisco 1
Totale 317
Nome #
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL 106
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL 95
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL 90
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 89
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 74
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL 71
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 6
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? 4
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey 3
Totale 538
Categoria #
all - tutte 2.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 3 2 0 1 1 0 0 3
2023/202445 4 0 1 5 0 6 1 6 0 3 2 17
2024/2025114 9 4 4 0 10 8 19 19 9 13 4 15
2025/2026369 26 22 9 57 46 14 43 28 102 22 0 0
Totale 538